Press releases

3
Apr 2018
20:51 E.S.T.

Cellectis Announces Launch of Follow-On Offering

Read more
3
Apr 2018
12:10 E.S.T.

Cellectis and Allogene Therapeutics Intend to Continue Strategic Cancer Immunotherapy Collaboration to Accelerate Development and Commercialization of Allogeneic Off-the-Shelf CAR T Therapies

Read more
13
Mar 2018
20:30 E.S.T.

Dr. Mathieu Simon to Retire as Cellectis’ Chief Operating Officer; Elsy Boglioli Named as Successor

Read more
12
Mar 2018
20:52 E.S.T.

Cellectis Reports 4th Quarter and Full Year 2017 Financial Results

Read more
8
Mar 2018
21:30 E.S.T.

Servier and Pfizer Announce Results of UCART19 First-in-Human Trials to Be Presented at the 44th EBMT (European Society for Blood and Marrow Transplantation) Annual Meeting

Read more
13
Feb 2018
05:00 E.S.T.

Two Issued U.S. Patents Granted to Cellectis for CRISPR Use in T-Cells

Read more
2
Jan 2018
21:30 E.S.T.

Cellectis to Present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018 at 12:00PM PT

Read more
12
Dec 2017
23:42 E.S.T.

Preliminary Data from Servier and Pfizer’s UCART19 Product Candidate Shows High Complete Remission Rate Across Two Phase I Adult and Pediatric Acute Lymphoblastic Leukemia Trials

Read more
4
Dec 2017
21:30 E.S.T.

Cellectis Appoints Elsy Boglioli to Executive Vice President, Strategy and Corporate Development

Read more
4
Dec 2017
21:30 E.S.T.

Cellectis Appoints Immuno-Oncology Leader Stéphane Depil to Position of Senior Vice President Research & Development and Chief Medical Officer

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US